Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05591443
Other study ID # weHeartClinic
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date May 2023
Est. completion date May 2026

Study information

Verified date October 2022
Source Centro Cardiologico Monzino
Contact Piergiuseppe Agostoni, Prof
Phone 0258002010
Email piergiuseppe.agostoni@ccfm.it
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Heart failure is the major pandemic of the 21st century. The number of patients and of Heart Failure-related deaths is progressively increasing. This means a devastating economic and health organization burden. In fact, chronic heart failure patients are at high risk of death, and the course of the disease is often insidious and uncertain with a progressive deterioration requiring the need for repeated and successive hospitalizations with an ominous prognosis: with each admission for acute heart failure there is a short-term improvement, a phase characterized by a degree of stability, and then a worsening phase follows until a new need for a new hospitalization. Moreover, with each subsequent hospitalization, myocardial function progressively declines, gradually worsening the patient's quality of life until the fatal event. For these reasons, one of the major unmet needs is the identification of patients with a negative trajectory of Heart Failure. Accordingly, early identification of Heart Failure worsening is mandatory to improve patient condition and reduce Heart Failure costs, which are mainly associated with hospitalizations. Our main goal through this project is to create clinical tool for detection of early signs of chronic heart failure (CHF) worsening that will allow timely therapeutic intervention. This timely manner intervention can lead to a much better outcome for the patient, possibly reducing the need for hospitalization or lower the number of hospitalization days. The aim of this project is to develop clinical decision tool based on artificial intelligence (AI) algorithms to early detect the signs of exacerbation of chronic heart failure and predict the risk of its progression, by integrating high quality medical data obtained through a wearable device (L.I.F.E. Italia Srl's "wearable clinic" - a vest with accessories, which is a TRL 9 medical grade sensorized garment, already available on the market). Specifically, the focus will be on the early detection of CHF worsening in patients who have already been diagnosed with CHF.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 120
Est. completion date May 2026
Est. primary completion date May 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Presence of symptoms and/or signs of HF - left ventricular ejection fraction (LVEF) =40%. LVEF values will be obtained by determining the reduced LV systolic function, by transthoracic echocardiographic assessment as recommended by European Association of Cardiovascular Imaging (EACVI) and American Society of Echocardiography position paper. - NYHA functional classes II-III). Exclusion Criteria: - NYHA functional class IV, - Candidates for left-ventricular assist device (LVAD) or heart transplant, as per latest definition of Heart Failure Association of the ESC. - Recent acute coronary syndrome within 1-year prior to the date of potential enrollment, - Indirect echocardiographic evidence of significantly elevated pulmonary pressures - Clinically relevant pulmonary hypertension - non-adherence to optimal medical treatment for CHF

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Centro Cardiologico Monzino

Outcome

Type Measure Description Time frame Safety issue
Primary Definition of an algorithm for heart failure worsening Development by artificial intelligence of an algorithm based on all collected variables able to identify Heart Failure worsening 6 months
Primary Identification of respiratory predictors of heart failure worsening Identification of which single respiratory parameters are related to Heart Failure worsening among all those collected by the L.I.F.E. device. 6 months
Primary Identification of ECG predictors of heart failure worsening Identification of which single ECG parameters are related to Heart Failure worsening among all those collected by the L.I.F.E. device. 6 months
Secondary Identification of nocturnal parameters related to heart failure worsening Identification of which nocturnal parameters are related to Heart Failure worsening among all those collected by the L.I.F.E. device. 6 months
Secondary Heart rate variability as marker of heart failure worsening Evaluation of daytime/night-time/overall Heart Rate Variability as a predictor of Heart Failure worsening 6 months
See also
  Status Clinical Trial Phase
Completed NCT03727646 - Nicotinamide Riboside in LVAD Recipients Early Phase 1
Withdrawn NCT03519477 - Comprehensive Medication Monitoring on Heart Failure Patient Outcomes N/A
Recruiting NCT05596760 - Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers N/A
Recruiting NCT05227872 - PVF in Decongestion of Heart Failure
Recruiting NCT05543720 - Evaluation of Nurse-led Integrated Care of Complex Patients Facilitated By Telemonitoring: The SMaRT Study N/A
Completed NCT04572425 - Virtual Reality for Pain Management in Advanced Heart Failure N/A
Recruiting NCT03202329 - Evaluation of Post-operative, Nurse-based Heart Failure Care in Non-cardiac Surgery N/A
Recruiting NCT03830957 - Efficacy and Safety of Ivabradine to Reduce Heart Rate Prior to Coronary CT-angiography in Advanced Heart Failure: Comparison With β-Blocker N/A
Recruiting NCT02672618 - Clinical Research to Explore Manifestations of Heart Failure Using Infrared Thermal Imaging Technology N/A
Recruiting NCT04179643 - NAN-101 in Patients With Class III Heart Failure Phase 1
Completed NCT04129658 - Heart Failure in Southern Sweden
Completed NCT03387813 - Hemodynamic-GUIDEd Management of Heart Failure N/A
Completed NCT04628325 - Effects of Furosemide Plus Small HSS in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF) Phase 3
Completed NCT03187470 - Left Ventricular Dyssynchrony in Multipole Pacing N/A
Completed NCT03385837 - Activity Level and Barriers to Participate of Cardiac Rehabilitation in Advanced Heart Failure Patients
Completed NCT04281849 - Balance, Aerobic Capacity, Mobility and Strength in Patients Hospitalized for Heart Failure (BAMS-HF) Program N/A
Not yet recruiting NCT04403659 - Telemonitoring of Patients Admitted in Hospital at Home With Acute Decompensated Heart Failure - Pilot Study N/A
Terminated NCT04142788 - RELieving Increasing oEdema Due to Heart Failure Phase 4
Active, not recruiting NCT04283994 - Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2) N/A
Completed NCT03722069 - Dietary Sodium Intake in Acute Heart Failure N/A